Ratings Central China New Life Limited

Equities

Market Closed - Hong Kong S.E. Other stock markets 04:08:42 2024-06-28 EDT			5-day change	1st Jan Change
1.48 ^HKD	0.00%		+0.68%	-3.27%

06-04	Central China New Life Limited Proposes Special Dividend for the Year Ended 31 December 2023	CI
05-06	Central China New Life Limited Announces Change of Principal Place of Business in Hong Kong	CI

The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Overall, and from a short-term perspective, the company presents an interesting fundamental situation.

Thanks to a sound financial situation, the firm has significant leeway for investment.
The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.07 for the 2024 fiscal year.
The company's share price in relation to its net book value makes it look relatively cheap.
The company has a low valuation given the cash flows generated by its activity.
This company will be of major interest to investors in search of a high dividend stock.
Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
For several months, analysts have been revising their EPS estimates roughly upwards.
The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
The opinion of analysts covering the stock has improved over the past four months.
Over the past twelve months, analysts' opinions have been strongly revised upwards.

According to forecast, a sluggish sales growth is expected for the next fiscal years.
The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
The company's earnings releases usually do not meet expectations.

	1st Jan change	Capi.	Investor Rating	ESG Refinitiv
CENTRAL CHINA NEW LIFE LIMITED	-3.27%	242M		-
CBRE GROUP, INC.	-4.28%	26.88B		B+
ZILLOW GROUP, INC.	-20.59%	10.87B		C-
CAPITALAND INVESTMENT LIMITED	-15.82%	9.83B		B-
JONES LANG LASALLE INCORPORATED	+8.69%	9.76B		B+
FIRSTSERVICE CORPORATION	-3.00%	6.84B		C-
COLLIERS INTERNATIONAL GROUP INC.	-8.85%	5.61B		B+
MAKKAH CONSTRUCTION AND DEVELOPMENT COMPANY	+28.26%	4.19B	-	-
JSL CONSTRUCTION & DEVELOPMENT CO., LTD.	+116.69%	2.4B	-	-
CUSHMAN & WAKEFIELD PLC	-3.70%	2.38B		C+

Investor Rating

Trading Rating

ESG Refinitiv

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality